The European Commission has updated its draft Q&A guideline on the EU Clinical Trials Regulation to clarify a range of issues, such as documentation and processes to be addressed in cases when a sponsor requests to extend an authorized clinical trial to another EU member state.
The draft guideline, which includes Q&As discussed progressively since December 2014, aims to support the implementation of the CTR (No 536/2014) by addressing frequently asked questions on technical aspects of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?